NxStage Medical - 48 Year Dividend Yield History | NXTM

Historical dividend payout and yield for NxStage Medical (NXTM) since 1971. The current TTM dividend payout for NxStage Medical (NXTM) as of February 14, 2019 is $0.00. The current dividend yield for NxStage Medical as of February 14, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.945B $0.394B
NxStage Medical, Inc. is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $129.916B 25.68
Medtronic (MDT) Ireland $122.526B 18.32
Stryker (SYK) United States $69.144B 25.38
Baxter (BAX) United States $38.548B 23.75
Zimmer Biomet Holdings (ZBH) United States $24.985B 16.03
Smith & Nephew SNATS (SNN) United Kingdom $16.606B 0.00
ResMed (RMD) United States $14.250B 27.02
Hill-Rom Holdings (HRC) United States $6.904B 21.35
Perrigo (PRGO) Ireland $6.603B 10.02
Phibro Animal Health (PAHC) United States $1.192B 17.13
Meridian Bioscience (VIVO) United States $0.698B 20.80
LeMaitre Vascular (LMAT) United States $0.486B 23.89
Owens & Minor (OMI) United States $0.470B 5.32
Utah Medical Products (UTMD) United States $0.339B 21.98
United-Guardian (UG) United States $0.091B 19.11